<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <link rel="stylesheet" href="../static/tls.css">
    <title>TLS</title>
</head>
<body>
    <div class="container">
        <img class="header-logo" src="../static/img_head_foot/logo.png" alt="Logo" />

        <div class="nav-item nav-home">
            <a href="{{ url_for('home') }}" class="nav-text">Home</a>
        </div>
        <div class="nav-item nav-research">
            <a href="{{ url_for('research') }}" class="nav-text">Research</a>
        </div>
        <div class="nav-item nav-join-us">
            <a href="{{ url_for('join_us') }}" class="nav-text">Join Us</a>
        </div>
        <div class="nav-item nav-our-team">
            <a href="{{ url_for('team') }}" class="nav-text">Our Team</a>
        </div>
        <div class="nav-item nav-awards">
            <a href="{{ url_for('awards') }}" class="nav-text">Awards</a>
        </div>
        <div class="nav-item nav-publications">
            <a href="{{ url_for('publications') }}" class="nav-text">Publications</a>
        </div>

        <div class="header-divider"></div>

        <div class="card1-container">
            <div class="card1-background"></div>
            <div class="card1-title1">Antitumor potential of CD39⁺ T cells in clear cell renal cell carcinoma</div>
            <img class="card1-profile-img" src="../static/tls/emmanuel.png" />
            <img class="card1-image" src="../static/tls/emmanuel_pesq.png" />
            <div class="card1-description1">Emmanuel investigates the role of CD39⁺ T cells within tertiary lymphoid structures (TLS) in patients with clear cell renal cell carcino- ma (ccRCC). Previous analyses revealed that CD39⁺CXCL13⁺ T cells are polyclonal, spatially organized in TLS, and exhibit an exhausted phenotype resembling tumor-specific T cells.</div>
            <div class="card1-description2">His project seeks to deeply characterize the transcriptional and phenotypic profile of these T cells and their interactions with B cells. Functional assays evaluate their proliferation, cytotoxic potential, and response to tumor antigens. Additionally, the study assesses the association between TLS maturation and patient response to immunotherapy. The ultimate goal is to explore strategies to reverse T cell exhaustion and enhance antitumor immunity in ccRCC.</div>
            <div class="card1-box">
            <div class="card1-box-title">Emmanuel V. O. Araújo, PHD Student</div>
            </div>
        </div>
        <div class="card2-container">
            <div class="card2-background"></div>
            <div class="card2-title">Therapeutic potential of germinal center B cells in clear cell renal cell carcinoma</div>
            <img class="card2-profile-img" src="../static/tls/ray.png" />
            <img class="card2-image" src="../static/tls/Ray_pesq.png" />
            <div class="card2-description"> Raylane's research explores the therapeutic potential of B cells derived from germinal centers (GC) within tertiary lymphoid structures (TLS) in clear cell renal cell carcinoma (ccRCC). The project aims to identify tumor-reactive B cell populations capable of generating high-affinity immunoglobulins against tumor antigens. These antibodies, naturally produced within intratumoral TLS, have been shown to promote tumor cell apoptosis. The study includes repertoire analysis of B cell receptors (BCRs), validation of antibody affinity and tumor-binding potential, and the design of novel chimeric antigen receptors based on selected BCRs. This strategy seeks to inform the development of personalized CAR-T cells specifically targeted against ccRCC.</div>
        </div>

        <div class="card3-container">
            <div class="card3-background"></div>
            <div class="card3-title">Spatial organization and functional profiling of tumor-infiltrating immune cells in endometrial cancer: insights for novel immunotherapeutic targets</div>
            <img class="card3-profile-img" src="../static/tls/Manu.svg" />
            <img class="card3-image" src="../static/tls/pesquisa3.png" />
            <div class="card3-description">Endometrial cancer is a common gynecological malignancy, and most patients do not respond to immune checkpoint inhibitors, such as anti-PD-1. This limited efficacy is largely attributed to the immunosuppressive tumor microenvironment and the heterogeneity of the immune infiltrate. Recent studies highlight the importance of tertiary lymphoid structures (TLS) in organizing effective antitumor immune responses. In this context, Maria Luisa's project aims to characterize the spatial organization and functionality of tumor-infiltrating immune cells in endometrial cancer. The study focuses on identifying features of mature TLS and their correlation with better clinical outcomes, with the ultimate goal of discovering new immunotherapeutic targets to enhance antitumor immunity in this cancer type.</div>
        </div>
        <div class="research-banner-background"></div>
        <div class="research-banner-text">Research in Development</div>

        <div class="footer">
            <div class="footer-line"></div>
            <img class="footer-icon1" src="../static/img_head_foot/iconeMedinaLab.png" />
            <div class="footer-copyright">© 2025 All Rights Reserved </div>
            <img class="footer-icon2" src="../static/img_head_foot/icone_instagram.png" />
        </div>
    </div>
</body>
</html>